These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32017279)

  • 1. HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis.
    Zhu Q; Dong H; Bukhari AA; Zhao A; Li M; Sun Y; Zhang X; Cao C; Su D; Liang X
    FASEB J; 2020 Mar; 34(3):4591-4601. PubMed ID: 32017279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
    Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ubiquitin-conjugating enzyme UBE2Q2 participates in HUWE1-mediated protection on renal tubulointerstitial fibrosis].
    Wang Z; Dong H; Li M; Liang XB
    Sheng Li Xue Bao; 2022 Feb; 74(1):117-124. PubMed ID: 35199132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.
    Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
    Kidney Int; 2006 May; 69(10):1733-40. PubMed ID: 16625151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis.
    Yuan C; Jin G; Li P; Wang W; Ge C; Pan Y; Zhang Q; Mo J; Kuang D; Liu L; Zhang X; Liang H; Zhang W; Tang X; Li Z; Liu J; Xu G; Chen X; Ding ZY; Zhang B
    Kidney Int; 2023 Oct; 104(4):769-786. PubMed ID: 37482091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
    Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
    Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
    He Y; Zhou J; Wan Q
    Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
    Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y
    Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
    Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
    Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
    [No Abstract]   [Full Text] [Related]  

  • 11. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway.
    Ye C; Tang H; Zhao Z; Lei CT; You CQ; Zhang J; Gao P; He FF; Chen S; Wang YM; Zhang C; Su H
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F760-F768. PubMed ID: 28100501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.
    Tan R; Zhang J; Tan X; Zhang X; Yang J; Liu Y
    J Am Soc Nephrol; 2006 Oct; 17(10):2781-91. PubMed ID: 16959829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
    Wang W; Ma BL; Xu CG; Zhou XJ
    Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein A deficiency exacerbates renal interstitial fibrosis following obstructive injury in mice.
    Tian S; Li C; Ran R; Chen SY
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):509-517. PubMed ID: 27916681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I γ Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6.
    Sun M; Cai J; Anderson RA; Sun Y
    J Biol Chem; 2016 Oct; 291(41):21461-21473. PubMed ID: 27557663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis.
    Sun H; Zhao A; Li M; Dong H; Sun Y; Zhang X; Zhu Q; Bukhari AA; Cao C; Su D; Liu Y; Liang X
    Cell Death Dis; 2020 Feb; 11(2):146. PubMed ID: 32094322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gypenosides inhibit renal fibrosis by regulating expression of related genes in rats with unilateral ureteral obstruction.
    Zhang Y; Zhang JE; Xiao HQ; Wu PY; Bai SJ
    J Nephrol; 2011; 24(1):112-8. PubMed ID: 20540031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
    J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the high-affinity leukotriene B4 receptor signaling in fibrosis after unilateral ureteral obstruction in mice.
    Kamata M; Amano H; Ito Y; Fujita T; Otaka F; Hosono K; Kamata K; Takeuchi Y; Yokomizo T; Shimizu T; Majima M
    PLoS One; 2019; 14(2):e0202842. PubMed ID: 30818366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRL4B
    Liu F; Cao L; Zhang T; Chang F; Xu Y; Li Q; Deng J; Li L; Shao G
    Biochem Biophys Res Commun; 2018 Jun; 501(2):440-447. PubMed ID: 29738775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.